First-line Therapy for Immune Thrombocytopenia: Time for Change
Main Author: | Roger E. G. Schutgens |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-10-01
|
Series: | HemaSphere |
Online Access: | http://journals.lww.com/10.1097/HS9.0000000000000783 |
Similar Items
-
Efficacy of high-dose methylprednisolone as a first-line therapy in adult patients with immune thrombocytopenia
by: Kaniye Aydın, et al.
Published: (2022-06-01) -
Possible Targets to Reduce Fatigue in Chronic Immune Thrombocytopenia Patients – An Explorative Study
by: Wobke E.M. van Dijk, et al.
Published: (2022-10-01) -
Dentoalveolar Procedures in Immune Thrombocytopenia; Systematic Review and an Institutional Guideline
by: Wobke E. M. van Dijk, et al.
Published: (2021-10-01) -
Pediatric immune thrombocytopenia: a focus on eltrombopag as second-line therapy
by: Giuseppe Palumbo, et al.
Published: (2023-12-01) -
Emerging Therapies in Immune Thrombocytopenia
by: Sylvain Audia, et al.
Published: (2021-03-01)